A Two-Part Trial Assessing the Effects of 7α-Methyl-19-Nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-Label Pilot Study Followed by a Randomized, Double-Blind, Placebo-Controlled Study
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Trestolone (Primary)
- Indications Andropause
- Focus Pharmacodynamics
- 15 Mar 2012 Planned end date changed from 1 Sep 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 10 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Dec 2008 New trial record.